Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456989 · ClinicalTrials.gov registry record · Phase 1
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
A Phase 1 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00456989 is a Phase 1 study that has completed, run by University of Louisville. The registered enrollment target is 39 participants.
The verdict
NCT00456989, a Phase 1 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This clinical research study is being done because there is no effective treatment for advanced androgen-independent prostate cancer. This study will determine if the combination of medications (Taxotere and Doxil) are effective in this kind of cancer.
Interventions
- DRUG Taxotere
- DRUG Doxil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2004-01 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00456989
The ClinicalTrials.gov registry entry for NCT00456989 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Taxotere is the first listed.
NCT00456989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00456989 about?
NCT00456989 is a clinical study titled "Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer". This clinical research study is being done because there is no effective treatment for advanced androgen-independent prostate cancer. This study will determine if the combination of medications (Taxotere and Doxil) are effective in this kind of cancer.
What is the current status of trial NCT00456989?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2004-01. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00456989?
The interventions under investigation include: Taxotere (DRUG), Doxil (DRUG).
Who is sponsoring clinical trial NCT00456989?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.